JPMorgan Chase & Co. Increases Stock Holdings in Teleflex Incorporated $TFX

JPMorgan Chase & Co. boosted its position in shares of Teleflex Incorporated (NYSE:TFX) by 41.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,343 shares of the medical technology company’s stock after acquiring an additional 36,178 shares during the period. JPMorgan Chase & Co. owned 0.28% of Teleflex worth $15,092,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB grew its position in shares of Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares in the last quarter. Hantz Financial Services Inc. boosted its stake in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after buying an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in Teleflex during the third quarter worth about $35,000. True Wealth Design LLC grew its position in Teleflex by 10,333.3% during the second quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock worth $37,000 after buying an additional 310 shares in the last quarter. Finally, Quent Capital LLC bought a new position in Teleflex in the 3rd quarter worth about $38,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Price Performance

TFX stock opened at $122.02 on Wednesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $143.32. The firm’s fifty day moving average is $111.31 and its 200 day moving average is $118.70. The firm has a market cap of $5.39 billion, a P/E ratio of -5.94, a P/E/G ratio of 0.76 and a beta of 0.87.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The business had revenue of $569.00 million during the quarter, compared to the consensus estimate of $912.57 million. During the same period in the prior year, the firm earned $3.89 earnings per share. The business’s revenue for the quarter was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th will be given a $0.34 dividend. The ex-dividend date is Friday, March 6th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex’s payout ratio is presently -6.62%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Royal Bank Of Canada boosted their price target on shares of Teleflex from $115.00 to $125.00 and gave the stock a “sector perform” rating in a research note on Friday, February 27th. Truist Financial raised their price objective on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Wells Fargo & Company lifted their price objective on shares of Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $140.83.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.